Adverse effects by frequency: Very common (>10% frequency): * Lower respiratory tract infection, including pneumonia * Upper respiratory tract infection * Rash * Anemia * Neutropenia Common (1-10% frequency): * Sepsis * Herpes virus infection * Urinary tract infection * Febrile neutropenia * Leucopenia * Thrombocytopenia * Anaphylactoid reactions * Hypersensitivity * Tachycardia * Hypotension * Hypertension * Bronchospasm * Hypoxia * Dyspnoea (shortness of breath) * Chest discomfort * Pharyngolaryngeal pain * Cough * Nasal congestion * Small bowel obstruction * Diarrhoea * Nausea * Urticaria (hives) * Itchiness * Flushing * Back pain * Cytokine release syndrome * Pyrexia (fever) * Rigors * Chills * Hyperhidrosis * Fatigue Uncommon (0.1-1% frequency): * Agranulocytosis * Coagulopathy * Red cell aplasia * Lymphopenia * Anaphylactic shock * Tumour lysis syndrome Rare (<0.1% frequency): * Hepatitis B infection or reactivation<unk>  has received a black box warning regarding the potential for it to cause progressive multifocal leukoencephalopathy and hepatitis B reactivation. Likewise it is also advised that doctors watch cautiously for small bowel obstruction, neutropenia, thrombocytopenia, infusion reactions or an increased risk for infection.
Ofatumumab
Daratumumab
Alirocumab
Lanadelumab
Acalabrutinib
Tralokinumab
Sacituzumab govitecan
Bezlotoxumab